COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,046 Articles (22,627 medRxiv, 8,419 bioRxiv)

Most recent first Previous |  Page 527: Articles 5261-5270  | Next

Emergence and Spread of SARS-CoV-2 Variants of Concern in Canada: a Retrospective Analysis from Clinical and Wastewater Data
CHAMPREDON, D., Becker, D., Peterson, S. W., Mejia, E., Hizon, N., Schertzer, A., Djebli, M., Xie, Y., Oloye, F. F., Asadi, M., Cantin, J., Brinkmann, M., McPhedran, K. N., Giesy, J. P., Mangat, C.
10.1101/2022.12.09.22283256 — Posted: 2022-12-13
Identifying and preventing fraudulent responses in online public health surveys: Lessons learned during the COVID-19 pandemic
Johnson, S. B., Wang, J., Calderon, G., Hager, E. R., Edwards, L. V., Berry, A. A., Liu, Y., Dinh, J., Summers, A. C., Connor, K. A., Collins, M. E., Pritchett, L., Marshall, B. R.
10.1101/2022.12.12.22283381 — Posted: 2022-12-13
Identification of a protein expression signature distinguishing early from organising diffuse alveolar damage in COVID-19 patients.
Ashwin, H., Milross, L., Wilson, J., Majo, J., Lee, J. T. H., Calder, G., Hunter, B., James, S., Lagos, D., Signoret, N., Filby, A., Bayraktar, O. A., Fisher, A. J., Kaye, P. M.
10.1101/2022.12.09.22283280 — Posted: 2022-12-13
Heat wave, COVID-19, and mortality excess in the 2022 summer: a cohort study on data from Italian surveillances.
Venturelli, F., Mancuso, P., Vicentini, M., Ottone, M., Storchi, C., Roncaglia, F., Bisaccia, E., Ferrarini, C., Pezzotti, P., Giorgi Rossi, P., The Reggio Emilia COVID19 Working group
10.1101/2022.12.12.22283336 — Posted: 2022-12-13
The Impact of COVID-19 Pandemic on Mental Health: A Scoping Review
Josiah, B. O., Ncube, F.
10.1101/2022.12.12.22283388 — Posted: 2022-12-13
Dynamical nonequilibrium molecular dynamics simulations identify allosteric sites and positions associated with drug resistance in the SARS-CoV-2 main protease
Chan, H. T. H., F. Oliveira, A. S., Schofield, C. J., Mulholland, A. J., Duarte, F.
10.1101/2022.12.10.519730 — Posted: 2022-12-12
Immunogenic fusion proteins induce neutralizing SARS-CoV-2 antibodies in the serum and milk of sheep
Jacobson, G., Kraakman, K., Wallace, O., Pan, J., Williamson, A., Hennebry, A., Smolenski, G., Cursons, R., Hodgkinson, S., Kelton, W.
10.1101/2022.12.11.519990 — Posted: 2022-12-12
Identification of genomic signatures and multiple lineage markers from the second and third wave samples of COVID-19 in Western Rajasthan, India
Gadepalli, R., Bokolia, N. P.
10.1101/2022.12.10.518819 — Posted: 2022-12-12
Using machine learning to detect coronaviruses potentially infectious to humans
Gonzalez-Isunza, G., Jawaid, M.- Z., Liu, P., Cox, D. L., Vazquez, M., Arsuaga, J.
10.1101/2022.12.11.520008 — Posted: 2022-12-12
Machine learning identifies a COVID-19-specific phenotype in university students using a mental health app
Shvetcov, A., Whitton, A., Kasturi, S., Zheng, W.-Y., Beames, J., Ibrahim, O., Han, J., Hoon, L., Mouzakis, K., Gupta, S., Venkatesh, S., Christensen, H., Newby, J.
10.1101/2022.12.07.22283234 — Posted: 2022-12-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).